These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 26101226)

  • 21. Comparison of the long-term efficacy and safety of generic tacrolimus, Tacrobell, with Prograf in liver transplant recipients.
    Choi HJ; Kim DG; Kwak BJ; Han JH; Hong TH; You YK
    Drug Des Devel Ther; 2018; 12():295-301. PubMed ID: 29483770
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics and Clinical Outcomes of Generic Tacrolimus (Hexal) Versus Branded Tacrolimus in De Novo Kidney Transplant Patients: A Multicenter, Randomized Trial.
    Arns W; Huppertz A; Rath T; Ziefle S; Rump LC; Hansen A; Budde K; Lehner LJ; Shipkova M; Baeumer D; Kroeger I; Sieder C; Klein T; Schenker P
    Transplantation; 2017 Nov; 101(11):2780-2788. PubMed ID: 28658202
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Are generic immunosuppressants safe and effective?
    Godman B; Baumgärtel C
    BMJ; 2015 Jun; 350():h3248. PubMed ID: 26101229
    [No Abstract]   [Full Text] [Related]  

  • 24. Generic immunosuppression in transplantation: current evidence and controversial issues.
    El Hajj S; Kim M; Phillips K; Gabardi S
    Expert Rev Clin Immunol; 2015 May; 11(5):659-72. PubMed ID: 25817258
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Report of the American Society of Transplantation conference on immunosuppressive drugs and the use of generic immunosuppressants.
    Alloway RR; Isaacs R; Lake K; Hoyer P; First R; Helderman H; Bunnapradist S; Leichtman A; Bennett MW; Tejani A; Takemoto SK
    Am J Transplant; 2003 Oct; 3(10):1211-5. PubMed ID: 14510694
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term follow-up of a phase III clinical trial comparing tacrolimus extended-release/MMF, tacrolimus/MMF, and cyclosporine/MMF in de novo kidney transplant recipients.
    Silva HT; Yang HC; Meier-Kriesche HU; Croy R; Holman J; Fitzsimmons WE; First MR
    Transplantation; 2014 Mar; 97(6):636-41. PubMed ID: 24521771
    [TBL] [Abstract][Full Text] [Related]  

  • 27. De novo use of generic tacrolimus in liver transplantation - a single center experience with one-yr follow-up.
    Dannhorn E; Cheung M; Rodrigues S; Cooper H; Thorburn D; Patch D; Burroughs AK; O'Beirne J
    Clin Transplant; 2014 Dec; 28(12):1349-57. PubMed ID: 25142496
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Kidney and liver organ transplantation in persons with human immunodeficiency virus: An Evidence-Based Analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(4):1-56. PubMed ID: 23074407
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neoral versus prograf in simultaneous pancreas-kidney transplantation with portal venous drainage: three-year results of a single-center, open-label, prospective, randomized pilot study.
    Boggi U; Vistoli F; Del Chiaro M; Signori S; Amorese G; Vahadia Bartolo T; Sgambelluri F; Barsotti M; Tregnaghi C; Paleologo G; Coppelli A; Giannarelli R; Rizzo G; Marchetti P; Mosca F
    Transplant Proc; 2005; 37(6):2641-3. PubMed ID: 16182772
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Meta-analysis of basiliximab for immunoprophylaxis in renal transplantation.
    Keown P; Balshaw R; Khorasheh S; Chong M; Marra C; Kalo Z; Korn A
    BioDrugs; 2003; 17(4):271-9. PubMed ID: 12899644
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparison of daclizumab to ATGAM induction in simultaneous pancreas-kidney transplant recipients on triple maintenance immunosuppression.
    Rasaiah SB; Light JA; Sasaki TM; Currier CB
    Clin Transplant; 2000 Aug; 14(4 Pt 2):409-12. PubMed ID: 10946780
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of generics in kidney transplant: mycophenolate mofetil 500 versus mycophenolate: 2-year results.
    Abdallah TB; Ounissi M; Cherif M; Helal I; Karoui C; Mhibik S; Bacha MM; Abderrahim E; Kheder A
    Exp Clin Transplant; 2010 Dec; 8(4):292-6. PubMed ID: 21143094
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is There Evidence to Support Brand to Generic Interchange of the Mycophenolic Acid Products?
    Phillips K; Reddy P; Gabardi S
    J Pharm Pract; 2017 Feb; 30(1):9-16. PubMed ID: 26043743
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A network meta-analysis of the efficacy of belatacept, cyclosporine and tacrolimus for immunosuppression therapy in adult renal transplant recipients.
    Goring SM; Levy AR; Ghement I; Kalsekar A; Eyawo O; L'Italien GJ; Kasiske B
    Curr Med Res Opin; 2014 Aug; 30(8):1473-87. PubMed ID: 24628478
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A multicenter, open-label, comparative trial of two daclizumab dosing strategies vs. no antibody induction in combination with tacrolimus, mycophenolate mofetil, and steroids for the prevention of acute rejection in simultaneous kidney-pancreas transplant recipients: interim analysis.
    Stratta RJ; Alloway RR; Hodge E; Lo A;
    Clin Transplant; 2002 Feb; 16(1):60-8. PubMed ID: 11982617
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of immunosuppression monotherapy after liver transplantation: a meta-analysis.
    Lan X; Liu MG; Chen HX; Liu HM; Zeng W; Wei D; Chen P
    World J Gastroenterol; 2014 Sep; 20(34):12330-40. PubMed ID: 25232269
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tacrolimus versus cyclosporin as primary immunosuppression for kidney transplant recipients.
    Webster A; Woodroffe RC; Taylor RS; Chapman JR; Craig JC
    Cochrane Database Syst Rev; 2005 Oct; (4):CD003961. PubMed ID: 16235347
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tacrolimus versus cyclosporin as primary immunosuppression for lung transplant recipients.
    Penninga L; Penninga EI; Møller CH; Iversen M; Steinbrüchel DA; Gluud C
    Cochrane Database Syst Rev; 2013 May; (5):CD008817. PubMed ID: 23728681
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Generic cyclosporine formulations: more open questions than answers.
    Cattaneo D; Perico N; Remuzzi G
    Transpl Int; 2005 Apr; 18(4):371-8. PubMed ID: 15773953
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Calcineurin inhibitor-free immunosuppression in pediatric renal transplantation: a viable option?
    Höcker B; Tönshoff B
    Paediatr Drugs; 2011 Feb; 13(1):49-69. PubMed ID: 21162600
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.